Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ankit Pulps & Boards is a prominent Indian manufacturer specializing in high-quality pharmaceutical excipients, particularly cellulose-based derivatives. Founded in 1988 and headquartered in Nagpur, the company is a leading producer of Microcrystalline Cellulose (MCC), which serves as a critical binder and filler in tablet and capsule formulations. Their product portfolio also includes specialized excipients such as Croscarmellose Sodium and Sodium Starch Glycolate, catering to the global pharmaceutical, nutraceutical, and food industries. The company maintains state-of-the-art manufacturing facilities that are WHO-GMP certified and holds several Drug Master Files (DMFs) with the US FDA. By providing essential ingredients for solid dosage forms, Ankit Pulps & Boards plays a vital role in the drug manufacturing supply chain across more than 40 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ankit Pulps & Boards.